RISK-FACTORS FOR ACCELERATED ATHEROSCLEROSIS IN RENAL-TRANSPLANT RECIPIENTS

被引：355
作者：
KASISKE, BL
机构：
来源：
AMERICAN JOURNAL OF MEDICINE | 1988年 / 84卷 / 06期
关键词：
D O I：
10.1016/0002-9343(88)90302-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：985 / 992
页数：8
相关论文
共 30 条
[1]  
ALONSO DR, 1977, AM J PATHOL, V87, P415
[2]   THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL-ALLOGRAFT RECIPIENTS [J].
BOUDREAUX, JP ;
MCHUGH, L ;
CANAFAX, DM ;
ASCHER, N ;
SUTHERLAND, DER ;
PAYNE, W ;
SIMMONS, RL ;
NAJARIAN, JS ;
FRYD, DS .
TRANSPLANTATION, 1987, 44 (03) :376-381
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]   EPIDEMIOLOGY OF ATHEROSCLEROSIS - AN UPDATED OVERVIEW [J].
CRIQUI, MH .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (05) :C18-C23
[5]   HYPERTENSION AND KIDNEY-TRANSPLANTATION [J].
CURTIS, JJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 7 (03) :181-196
[6]  
DIXON WJ, 1985, BMDP STATISTICAL SOF
[7]   ALTERATIONS IN LIPID AND CARBOHYDRATE-METABOLISM ATTRIBUTABLE TO CYCLOSPORINE-A IN RENAL-TRANSPLANT RECIPIENTS [J].
HARRIS, KPG ;
RUSSELL, GI ;
PARVIN, SD ;
VEITCH, PS ;
WALLS, J .
BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6512) :16-16
[8]  
HESS ML, 1983, CIRCULATION, V68, P94
[9]  
HEULE H, 1981, SCHWEIZ MED WOCHENSC, V20, P709
[10]   THE OPTIMAL ANTITHROMBOTIC DOSE OF ASPIRIN [J].
HIRSH, J .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (09) :1582-1583
123